ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FDBK Feedback Plc

62.50
0.00 (0.00%)
16 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 62.50 60.00 65.00 62.50 62.50 62.50 168 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.86 8.33M

AIM Schedule 1 - Feedback Plc (8919F)

30/04/2014 9:41am

UK Regulatory


TIDMFDBK

RNS Number : 8919F

AIM

30 April 2014

 
              ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION 
               IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM 
                                          RULES") 
------------------------------------------------------------------------------------------ 
 
 COMPANY NAME: 
------------------------------------------------------------------------------------------ 
 Feedback plc (the "Company" or "Feedback") 
------------------------------------------------------------------------------------------ 
 COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY 
  TRADING ADDRESS (INCLUDING POSTCODES) : 
------------------------------------------------------------------------------------------ 
  26 Red Lion Square, London WC1R 4AG 
------------------------------------------------------------------------------------------ 
 COUNTRY OF INCORPORATION: 
------------------------------------------------------------------------------------------ 
 United Kingdom 
------------------------------------------------------------------------------------------ 
 COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED 
  BY AIM RULE 26: 
------------------------------------------------------------------------------------------ 
 www.fbk.com 
------------------------------------------------------------------------------------------ 
 COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, 
  IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING 
  POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE 
  TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED: 
------------------------------------------------------------------------------------------ 
 The acquisition of Cambridge Computed Imaging Limited ("CCI") 
  and TexRAD Limited ("TexRAD") will result in a reverse takeover 
  under AIM Rule 14. The business of the enlarged group, of 
  which the main country of operation will be the UK, will be 
  that of CCI and TexRAD. 
 
  CCI was formed in 2001 by former employees of the Department 
  of Radiology at Papworth Hospital (now Papworth Hospital NHS 
  Foundation Trust) to provide picture archiving and communication 
  systems (PACS) for the display, review, manipulation and archiving 
  of medical images. TexRAD was spun out from the University 
  of Sussex in 2011 and was established to develop textural 
  analysis tools for the detection and measurement of quantitative 
  imaging biomarkers within cancer tumours. 
 
  CCI specialises in providing software that helps doctors use 
  medical images in diagnosis and treatment. Since its foundation, 
  CCI has focused on supporting the needs of Papworth Hospital, 
  the UK's largest specialist cardiothoracic hospital, and other 
  facilities where its software is used to support diagnosis, 
  treatment planning, treatment response and knowledge sharing 
  within multi-disciplinary teams. 
 
  TexRAD offers an innovative quantitative tool to those researching 
  the diagnosis, prognosis and treatment response of cancer. 
  The technology enables quantitative textural analysis of heterogeneity 
  to be found in routinely acquired clinical diagnostic images 
  which could serve to risk stratify tumours and assist in response 
  evaluation. Research customers have shown that using TexRAD's 
  quantitative textural analysis, heterogeneity could further 
  add value to existing markers of tumour size, density and 
  perfusion as a quantitative imaging biomarker and potentially 
  assist in clinical decision making by optimising care pathways 
  for improved patient outcomes and provide cost-effective patient 
  management. 
 
  Both Tom Charlton and Trevor Brown are participating in the 
  Subscription. In addition, Tom Charlton is a shareholder in 
  CCI. The participation of Messrs Charlton and Brown in the 
  Subscription and Mr Charlton's entry into the CCI acquisition 
  agreement are related party transactions in accordance with 
  the AIM Rules. 
------------------------------------------------------------------------------------------ 
 DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS 
  AS TO TRANSFER OF THE SECURITIES (i.e. where known, number 
  and type of shares, nominal value and issue price to which 
  it seeks admission and the number and type to be held as treasury 
  shares): 
------------------------------------------------------------------------------------------ 
 190,746,746 ordinary shares of 0.25p per share. 
 
  There are no restrictions on the transfer of securities. 
------------------------------------------------------------------------------------------ 
 CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED 
  MARKET CAPITALISATION ON ADMISSION: 
------------------------------------------------------------------------------------------ 
 New capital to be raised on Admission to AIM: GBP300,000, 
  GBP260,000 of which is being subscribed for by directors of 
  the Company. 
  Anticipated market capitalisation: approximately GBP2.38 million. 
------------------------------------------------------------------------------------------ 
 PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION: 
------------------------------------------------------------------------------------------ 
 53.11% 
------------------------------------------------------------------------------------------ 
 DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH 
  THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES 
  (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED: 
------------------------------------------------------------------------------------------ 
 None 
------------------------------------------------------------------------------------------ 
 FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS 
  (underlining the first name by which each is known or including 
  any other name by which each is known): 
------------------------------------------------------------------------------------------ 
 Nicholas Nick Steven Shepheard (Chairman and Chief Executive) 
  Simon Gregory Barrell (Non-executive Director) 
  Trevor Edward Brown (Non-executive Director) 
  Thomas Tom William George Charlton (Non-executive Director) 
------------------------------------------------------------------------------------------ 
 FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED 
  AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER 
  ADMISSION (underlining the first name by which each is known 
  or including any other name by which each is known): 
------------------------------------------------------------------------------------------ 
                           As at the date of this                 As at admission 
                                 announcement 
                          Number of       Percentage of       Number of      Percentage of 
                       Ordinary Shares   Existing Shares   Ordinary Shares    Issued Share 
                                               (%)                            Capital (%) 
    Trevor Edward 
     Brown               39,189,111           29.93          49,589,111          26.00 
    Thomas Tom 
     William George 
     Charlton            34,084,808           26.03          46,717,408          24.49 
    William Roy 
     Ruffler              9,397,893           7.18           12,597,893           6.60 
    Prof John 
     Westcott             5,999,287           4.58            5,999,287           3.15 
    Nicholas Nick 
     Shepheard            5,000,000           3.82            5,000,000           2.62 
    University of 
     Sussex                   0               0.00            9,400,000           4.93 
------------------------------------------------------------------------------------------ 
 NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 
  2, PARAGRAPH (H) OF THE AIM RULES: 
------------------------------------------------------------------------------------------ 
 None 
------------------------------------------------------------------------------------------ 
 (i) ANTICIPATED ACCOUNTING REFERENCE DATE 
  (ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION 
  DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited 
  interim financial information) 
  (iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS 
  PURSUANT TO AIM RULES 18 AND 19: 
------------------------------------------------------------------------------------------ 
 i) 31 May 
  ii) 30 November 2013 
  iii) 30 November 2014, 28 February 2015, 30 November 2015 
------------------------------------------------------------------------------------------ 
 EXPECTED ADMISSION DATE: 
------------------------------------------------------------------------------------------ 
 19 May 2014 
------------------------------------------------------------------------------------------ 
 NAME AND ADDRESS OF NOMINATED ADVISER: 
------------------------------------------------------------------------------------------ 
 Sanlam Securities UK Limited,10 King William Street, London 
  EC4N 7TW 
------------------------------------------------------------------------------------------ 
 NAME AND ADDRESS OF BROKER: 
------------------------------------------------------------------------------------------ 
 Joint Broker - Sanlam Securities UK Limited,10 King William 
  Street, London EC4N 7TW 
  Joint Broker - Peterhouse Corporate Finance Limited, 31 Lombard 
  Street, London EC3V 9BQ 
------------------------------------------------------------------------------------------ 
 OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE 
  (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE 
  AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL 
  DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES: 
------------------------------------------------------------------------------------------ 
 Sanlam Securities UK Limited,10 King William Street, London 
  EC4N 7TW 
 
  The admission document containing full details regarding the 
  applicant and admission of its securities will be available 
  from the Company's website www.fbk.com. 
------------------------------------------------------------------------------------------ 
 DATE OF NOTIFICATION: 
------------------------------------------------------------------------------------------ 
 30 April 2014 
------------------------------------------------------------------------------------------ 
 NEW/ UPDATE: 
------------------------------------------------------------------------------------------ 
 NEW 
------------------------------------------------------------------------------------------ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

PAAWGURWCUPCURU

1 Year Feedback Chart

1 Year Feedback Chart

1 Month Feedback Chart

1 Month Feedback Chart

Your Recent History

Delayed Upgrade Clock